Review



anti phospho igf1r  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc anti phospho igf1r
    Anti Phospho Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 430 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/Phospho-IGF-I+Receptor+beta+(Tyr1135%2F1136)%2FInsulin+Receptor+beta+(Tyr1150%2F1151)+Rabbit+mAb/bio_rxiv__64898__2026__03__25__714159-324-30-34
    Average 96 stars, based on 430 article reviews
    anti phospho igf1r - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Phospho-proteomics:

    Article Title: Disruption of Man-6-P-Dependent Sorting to Lysosomes Confers IGF1R-Mediated Apoptosis Resistance
    Article Snippet: .. The following concentrations of primary antibodies were used: 1:1000 for the rabbit anti-IGF1R (D23H3, 9750, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-phospho-IGF1R that recognizes phosphorylation on tyrosines 1135/1136 within IGF1R (3024, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-AKT (9272, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-phospho-AKT that recognizes phosphorylation on serine 473 within AKT (4060, Cell Signaling, Leiden, The Netherlands); and 1:10,000 for the mouse anti-α-tubulin (Merck, Hoeilaart, Belgium). .. After several TBS-T washes, the membranes were incubated with secondary antibodies (IRDye R 680RD for Goat anti-Rabbit or IRDye R 800CW for Goat anti-Mouse, LI-COR Biotechnology, Lincoln, NB, USA) at RT for 1 h. Signals were detected using the Amersham TM Typhoon scanner (General Boston Electrics, Boston, MA, USA).

    Article Title: Disruption of Man-6-P-Dependent Sorting to Lysosomes Confers IGF1R-Mediated Apoptosis Resistance
    Article Snippet: .. The following concentrations of primary antibodies were used: 1:1000 for the rabbit anti-IGF1R (D23H3, 9750, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-phospho-IGF1R that recognizes phosphorylation on tyrosines 1135/1136 within IGF1R (3024, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-AKT (9272, Cell Signaling, Leiden, The Netherlands); 1:1000 for the rabbit anti-phospho-AKT that recognizes phosphorylation on serine 473 within AKT (4060, Cell Signaling, Leiden, The Netherlands); and 1:10,000 for the mouse anti-α-tubulin (Merck, Hoeilaart, Belgium). .. After several TBS-T washes, the membranes were incubated with secondary antibodies (IRDyeR 680RD for Goat anti-Rabbit or IRDyeR 800CW for Goat anti-Mouse, LI-COR Biotechnology, Lincoln, NB, USA) at RT for 1 h. Signals were detected using the AmershamTM Typhoon scanner (General Boston Electrics, Boston, MA, USA).

    other:

    Article Title: Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in Alzheimer’s disease
    Article Snippet: rabbit anti-IGF1R , Cell Signaling Technology , Cat# 3027S; RRID: AB_2122378.

    Incubation:

    Article Title: Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in Alzheimer’s disease
    Article Snippet: Tissues were blocked in 5% Normal Goat Serum (Jackson ImmunoResearch, West Grove, PA) in PBS +1% BSA +0.3% Triton X-100 for 30 min at room temperature. .. Samples were incubated at 4°C with the following primary antibodies in 5% Normal Goat Serum in PBS +1% BSA +0.3% Triton X-100 + 0.1% NaN3: hamster anti-mouse CD31 (1:1000, cat. #MAB1398Z, Millipore), rabbit anti-ERG (1:100, cat. #97249, Cell Signaling Technology), rabbit anti-LEF1 (1:100, cat. #2230, Cell Signaling Technology), rabbit anti-SOX17 (1:100, cat. #ab224637, Abcam), rat anti-TfR (1:100, cat. #NB100-64979, Novus Biologicals), rabbit anti-GLUT-1 (1:100, cat. #21829-1-AP, Proteintech), rabbit anti-IGF1R (1:100, cat. #3027S, Cell Signaling Technology), rabbit anti-PALMD (1:50, cat. #16531-1-AP, Proteintech) and rabbit anti-TPD52 (1:50, cat. #A10254; Abclonal). ..

    Article Title: Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in Alzheimer's disease.
    Article Snippet: Tissues were blocked in 5% Normal Goat Serum (Jackson ImmunoResearch, West Grove, PA) in PBS +1% BSA +0.3% Triton X-100 for 30 min at room temperature. .. Samples were incubated at 4 C with the following primary antibodies in 5% Normal Goat Serum in PBS +1% BSA +0.3% Triton X-100 + 0.1% NaN3: hamster anti-mouse CD31 (1:1000, cat. #MAB1398Z, Millipore), rabbit anti-ERG (1:100, cat. #97249, Cell Signaling Technology), 22 Cell Reports 42, 113392, November 28, 2023 rabbit anti-LEF1 (1:100, cat. #2230, Cell Signaling Technology), rabbit anti-SOX17 (1:100, cat. #ab224637, Abcam), rat anti-TfR (1:100, cat. #NB100-64979, Novus Biologicals), rabbit anti-GLUT-1 (1:100, cat. #21829-1-AP, Proteintech), rabbit anti-IGF1R (1:100, cat. #3027S, Cell Signaling Technology), rabbit anti-PALMD (1:50, cat. #16531-1-AP, Proteintech) and rabbit anti-TPD52 (1:50, cat. #A10254; Abclonal). ..

    Western Blot:

    Article Title: Spinal dorsal horn IGF1 mediates the preventive effect of electroacupuncture on cisplatin-induced peripheral neuropathy via neuronal IGF1R in mice.
    Article Snippet: .. The rabbit anti-p-IGF1R (1:1000, Cell Signaling catalog no.3918S), rabbit anti-IGF1R (1:1000, Cell Signaling catalog no.3918S), mouse antiGRK2 (1:1000, Santa cruz catalog no.Sc-13143) or β-actin (1:10,000, Proteintech catalog no.HRP-66009) primary antibodies were used to evaluate the levels of p-IGF1R, IGF1R, GRK2 by Western blotting according to our previous method [17]. ..

    Article Title: Spinal dorsal horn IGF1 mediates the preventive effect of electroacupuncture on cisplatin-induced peripheral neuropathy via neuronal IGF1R in mice
    Article Snippet: .. The rabbit anti-p-IGF1R (1:1000, Cell Signaling catalog no.3918S), rabbit anti-IGF1R (1:1000, Cell Signaling catalog no.3918S), mouse anti-GRK2 (1:1000, Santa cruz catalog no.Sc-13143) or β-actin (1:10,000, Proteintech catalog no.HRP-66009) primary antibodies were used to evaluate the levels of p-IGF1R, IGF1R, GRK2 by Western blotting according to our previous method [ ]. ..



    Similar Products

    96
    Cell Signaling Technology Inc anti phospho igf1r
    Anti Phospho Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/Phospho-IGF-I+Receptor+beta+(Tyr1135%2F1136)%2FInsulin+Receptor+beta+(Tyr1150%2F1151)+Rabbit+mAb/bio_rxiv__64898__2026__03__25__714159-324-30-34
    Average 96 stars, based on 1 article reviews
    anti phospho igf1r - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit anti igf1r antibody
    Knockdown of <t>Igf1r</t> in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.
    Rabbit Anti Igf1r Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/pmc12972989-310-56-60
    Average 86 stars, based on 1 article reviews
    rabbit anti igf1r antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc igf1r β
    Knockdown of <t>Igf1r</t> in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.
    Igf1r β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/Vimentin+XP+Rabbit+mAb/pm41740834-231-57-58
    Average 98 stars, based on 1 article reviews
    igf1r β - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc 615 rabbit anti igf1r antibody
    Knockdown of <t>Igf1r</t> in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.
    615 Rabbit Anti Igf1r Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/pm41655695-292-63-68
    Average 86 stars, based on 1 article reviews
    615 rabbit anti igf1r antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti igf1r
    Knockdown of <t>Igf1r</t> in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.
    Anti Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/IGF-I+Receptor+beta+XP+Rabbit+mAb/us12540143-571-60-61
    Average 96 stars, based on 1 article reviews
    anti igf1r - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc antibodies against igf1r
    IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of <t>IGF1R</t> in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Antibodies Against Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/IGF-I+Receptor+beta+XP+Rabbit+mAb/pmc12731083-86-12-16
    Average 96 stars, based on 1 article reviews
    antibodies against igf1r - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc igf1r
    IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of <t>IGF1R</t> in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/IGF-I+Receptor+beta+XP+Rabbit+mAb/pmc12667387-194-29-31
    Average 96 stars, based on 1 article reviews
    igf1r - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit anti igf1r
    IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of <t>IGF1R</t> in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Rabbit Anti Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/Phospho-IGF-I+Receptor+beta+(Tyr1135)+Rabbit+mAb/pmc12642377-88-8-11
    Average 95 stars, based on 1 article reviews
    rabbit anti igf1r - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit anti p igf1r
    IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of <t>IGF1R</t> in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.
    Rabbit Anti P Igf1r, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+igf1r/pmc12642377-3-0-4
    Average 86 stars, based on 1 article reviews
    rabbit anti p igf1r - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    Knockdown of Igf1r in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.

    Journal: The Journal of Biological Chemistry

    Article Title: Downregulation of ClC-3 chloride channels in dorsal root ganglia neurons contributes to bone metastasis-induced pain

    doi: 10.1016/j.jbc.2026.111268

    Figure Lengend Snippet: Knockdown of Igf1r in DRG neurons disrupts intrathecal IGF1-induced activation of AKT signaling as well as the upregulated expression of HDAC2, the decreased expression of ClC-3 protein and pain hypersensitivity in na9;ve rats . A and B , RT-qPCR analysis and western blotting analysis of IGF1R mRNA and protein abundance in L4/5 DRG tissues from sham and BCP rats at 14 days after tumor cells inoculation. n = 6–7 rats per group. C , representative images showing the colocalization of IGF1R, HDAC2, and ClC-3 in DRG neurons. The scale bar represents 25 μm. D – F , western blotting analysis of p-AKT ( E ) and AKT ( F ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). D , representative blots are shown. G – I , western blotting analysis of HDAC2 ( H ) and ClC-3 ( I ) protein abundance in ipsilateral L4/5 DRG tissues obtained from IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP, respectively (n = 4 rats per group). G , representative blots are shown. J and K , assessment of ipsilateral PWT and PWL for IGF1-treated naïve rats that received intrathecal LV-shIGF1R and the control LV-GFP (n = 10 rats per group). L , assessment of animal’s locomotor function before and after intrathecal drug administration (n = 10 rats per group). Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( A )–( B ); one-way ANOVA followed by Dunnett's post hoc test for ( E )–( I ) two-way ANOVA with Sidak’s post hoc test for ( J )–( L ). BCP, bone cancer pain; DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; IGF1, insulin-like growth factor 1; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold; RT-qPCR, real-time quantitative PCR.

    Article Snippet: The membranes were blocked with 5% nonfat milk in TBST [20 mM Tris–HCl (pH 7.5), 150 mM NaCl, and 0.05% Tween 20] for 60 min at room temperature and then incubated with the following primary antibodies at 4 °C overnight: rabbit anti-ClC-3 antibody (1:1000, Abcam), rabbit anti-HDAC2 antibody (1:1000, Merck Millipore), rabbit anti-IGF1 antibody (1:1000, Abcam), rabbit anti-IGF1R antibody (1:1000, Cell Signaling Technology),rabbit anti-p-AKT antibody (1:1000, Cell Signaling Technology), rabbit anti-AKT antibody (1:2000, Cell Signaling Technology), mouse anti-β-actin (1:2000, Santa Cruz Biotechnology).

    Techniques: Knockdown, Activation Assay, Expressing, Quantitative RT-PCR, Western Blot, Quantitative Proteomics, Control, Histone Deacetylase Assay, Real-time Polymerase Chain Reaction

    Knockdown of Igf1r in DRG neurons impairs HDAC2-mediated transcriptional repression of Clc-3 gene, reduces neuronal excitability and attenuates pain hypersensitivity in bone metastasis model rats . A – E , western blotting analysis of p-AKT ( B ), AKT ( C ), HDAC2 ( D ) and ClC-3 ( E ) abundance in ipsilateral L4/5 DRG tissues from intrathecal LV-GFP and LV-shIGF1R treated rats at 14 days after tumor cells inoculation. n = 4 to 6 rats per group. A , representative blots are shown. F – H , electrophysiological analyses of neuronal excitability in ipsilateral L4/5 DRG neurons of bone metastasis model rats that received intrathecal LV-GFP and LV-shIGF1R, recorded at 14 days after tumor cells inoculation. F , representative neuronal action potentials evoked by a large depolarizing current pulse (1-s, 2-fold AP rheobase) are shown. The scale bar represents 20 mV, 100 ms. G and H , plots of threshold potential and rheobase are shown. n = 10∼20 cells from three rats per group. I and J , assessment of ipsilateral PWT ( I ) and PWL ( J ) from intrathecal LV-GFP and LV-shIGF1R treated rats after tumor cells inoculation. n = 10 rats per group. K , assessment of animal’s locomotor function by inclined-plate test, compared before and after drug administration. n = 10 rats per group. Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( B )–( H ); two-way ANOVA with Sidak’s post hoc test for ( I )–( K ). DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold.

    Journal: The Journal of Biological Chemistry

    Article Title: Downregulation of ClC-3 chloride channels in dorsal root ganglia neurons contributes to bone metastasis-induced pain

    doi: 10.1016/j.jbc.2026.111268

    Figure Lengend Snippet: Knockdown of Igf1r in DRG neurons impairs HDAC2-mediated transcriptional repression of Clc-3 gene, reduces neuronal excitability and attenuates pain hypersensitivity in bone metastasis model rats . A – E , western blotting analysis of p-AKT ( B ), AKT ( C ), HDAC2 ( D ) and ClC-3 ( E ) abundance in ipsilateral L4/5 DRG tissues from intrathecal LV-GFP and LV-shIGF1R treated rats at 14 days after tumor cells inoculation. n = 4 to 6 rats per group. A , representative blots are shown. F – H , electrophysiological analyses of neuronal excitability in ipsilateral L4/5 DRG neurons of bone metastasis model rats that received intrathecal LV-GFP and LV-shIGF1R, recorded at 14 days after tumor cells inoculation. F , representative neuronal action potentials evoked by a large depolarizing current pulse (1-s, 2-fold AP rheobase) are shown. The scale bar represents 20 mV, 100 ms. G and H , plots of threshold potential and rheobase are shown. n = 10∼20 cells from three rats per group. I and J , assessment of ipsilateral PWT ( I ) and PWL ( J ) from intrathecal LV-GFP and LV-shIGF1R treated rats after tumor cells inoculation. n = 10 rats per group. K , assessment of animal’s locomotor function by inclined-plate test, compared before and after drug administration. n = 10 rats per group. Data are presented as mean ± SEM. ∗ p < 0.05, ∗∗∗ p < 0.001, ns, not significant, unpaired t test for ( B )–( H ); two-way ANOVA with Sidak’s post hoc test for ( I )–( K ). DRG, dorsal root ganglion; HDAC2, histone deacetylase 2; LV-GFP, lentivirus expressing green fluorescent protein; p-AKT, phosphorylated AKT; PWL, paw withdrawal latency; PWT, paw withdrawal threshold.

    Article Snippet: The membranes were blocked with 5% nonfat milk in TBST [20 mM Tris–HCl (pH 7.5), 150 mM NaCl, and 0.05% Tween 20] for 60 min at room temperature and then incubated with the following primary antibodies at 4 °C overnight: rabbit anti-ClC-3 antibody (1:1000, Abcam), rabbit anti-HDAC2 antibody (1:1000, Merck Millipore), rabbit anti-IGF1 antibody (1:1000, Abcam), rabbit anti-IGF1R antibody (1:1000, Cell Signaling Technology),rabbit anti-p-AKT antibody (1:1000, Cell Signaling Technology), rabbit anti-AKT antibody (1:2000, Cell Signaling Technology), mouse anti-β-actin (1:2000, Santa Cruz Biotechnology).

    Techniques: Knockdown, Western Blot, Histone Deacetylase Assay, Expressing

    IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of IGF1R in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: Biomedicines

    Article Title: Single-Cell Analysis Links C7+ Cancer-Associated Fibroblasts with Incomplete Resection in Platinum-Sensitive Relapsed Ovarian Cancer

    doi: 10.3390/biomedicines13123011

    Figure Lengend Snippet: IGF-I inhibits anoikis and promotes migration in ovarian cancer cells. ( A , B ) Western blot analysis showing the knockout efficiency of IGF1R in COV318 ( A ) and SKOV3 ( B ) cells. ( C ) Following IGF-I treatment, anoikis levels in IGF1R knockout (KO) COV318 cells were significantly increased compared to the negative control (NC) group. ( D ) Quantitative analysis of anoikis in COV318 cells. ( E ) IGF1R knockout SKOV3 cells exhibited significantly elevated anoikis levels after IGF-I treatment compared with the NC group. ( F ) Quantitative analysis of anoikis in SKOV3 cells. ( G , H ) Scratch assay demonstrating that IGF-I treatment failed to promote migration in IGF1R knockout COV318 ( G ) and SKOV3 ( H ) cells. Scale bar, 200 μm. ( I , J ) Quantitative analysis of migration rate in COV318 ( I ) and SKOV3 ( J ) cells from scratch assay. ( K , L ) Trans-well migration assay further confirmed that IGF-I inhibited migration of IGF1R knockout COV318 ( K ) and SKOV3 ( L ) cells. Scale bar, 100 μm. ( M , N ) Quantitative analysis of Trans-well migration in COV318 ( M ) and SKOV3 ( N ) cells. Significance thresholds were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: Membranes were blocked and subsequently incubated overnight at 4 °C with primary antibodies against IGF1R (#9750, Cell Signaling Technology).

    Techniques: Migration, Western Blot, Knock-Out, Negative Control, Wound Healing Assay